Apalutamide and its use in the treatment of prostate cancer.

•  
• Overview
•  
• Research
•  
• Identity
•  
• Additional Document Info
•  
• View All
•  

Overview

authors

• Borno, Hala T
• Small, Eric J

publication date

• January 1, 2018

published in

• Future oncology (London, England)  Journal

has subject area

• Androgen Antagonists
• Clinical Trials, Phase III as Topic
• Humans
• Male
• Neoplasm Metastasis
• Neoplasm Staging
• Patient Reported Outcome Measures
• Prostatic Neoplasms
• Prostatic Neoplasms, Castration-Resistant
• Randomized Controlled Trials as Topic
• Signal Transduction
• Thiohydantoins
• Treatment Outcome

Research

Keywords

• androgen signaling inhibitor
• apalutamide
• castration-resistant prostate cancer
• nonmetastatic
• prostate cancer

Identity

Digital Object Identifier (DOI)

• https://doi.org/10.2217/fon-2018-0546

PubMed ID

• 30426794

Additional Document Info

start page

• 591

end page

• 599

volume

• 15

issue

• 6